Trademark: SEQUESSOME TECHNOLOGY 1505839
Word
SEQUESSOME TECHNOLOGY
ID
1505839
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
20 December 2011
Registration Date
20 December 2011
Renewal Date
20 December 2031

Service

Goods and Services:
Class 5:
Pharmaceutical preparations and substances; veterinary and sanitary preparations and substances; chemical preparations for pharmaceutical purposes; pharmaceuticals in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations of vesicles; chemical preparations in the form of vesicles for medical and veterinary purposes; chemical membranes and chemical aggregates for medical and veterinary purposes; preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances; cosmeceutical preparations for medical use; anti-inflammatory drugs; lipids for topical and parenteral use; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, alzheimer's disease, gout or macular degeneration, such as AMD, or fungal infection, and disorders related to fatty acid deficiencies